US Stock MarketDetailed Quotes

FINV FinVolution

Watchlist

6.910
+0.130+1.92%

Close Jan 3 16:00 ET

6.910
0.0000.00%

Post 16:00 ET

1.80BMarket Cap6.04P/E (TTM)

FinVolution Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

FinVolution Q3 2024 Earnings Date

Currency：USDNov 18, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	466.84M	--
		+6.59%
EPS	--	0.34	--
		+21.80%

Analyst Rating

Buy

Dec 31, 2024

FinVolution Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
Nov 14, 2022	2022/Q3	2.525B / 2.800B	--
Aug 22, 2022	2022/Q2	2.666B / 2.600B	--
Aug 25, 2020	2020/Q2	1.810B / --	--
May 27, 2020	2020/Q1	2.106B / 650.928M	--
Mar 19, 2020	2019/Q4	1.233B / 1.114B	--

DatePeriodRevenue/EstimateEarnings Call

Nov 14, 20222022/Q32.525B / 2.800B--

Aug 22, 20222022/Q22.666B / 2.600B--

Aug 25, 20202020/Q21.810B / ----

May 27, 20202020/Q12.106B / 650.928M--

Mar 19, 20202019/Q41.233B / 1.114B--

Unlock Free Earnings Estimates

Open Account

FinVolution Earnings Reports

FinVolution | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 19, 2024 06:07 ET

FinVolution | 6-K: Report of foreign private issuer (related to financial reporting)

Aug 21, 2024 06:05 ET

FinVolution | 6-K: Report of foreign private issuer (related to financial reporting)

May 16, 2024 06:11 ET

FinVolution | 20-F: FY2023 Annual Report

Apr 25, 2024 16:09 ET

Trending US Stocks

Symbol Mini Chart % Chg

DexCom

DXCM

+3.27%

Collegium Pharmaceutical

Unlock the Full List

Analysis

Analyst Rating

Updated: Dec 31, 2024

Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data